Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria ; volume:16 ; number:1 ; day:16 ; month:4 ; year:2016 ; pages:1-15 ; date:12.2016
BMC infectious diseases ; 16, Heft 1 (16.4.2016), 1-15, 12.2016
- Creator
-
Boiron, L.
- Contributor
-
Joura, E.
Largeron, N.
Prager, B.
Uhart, M.
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-1483-5
- URN
-
urn:nbn:de:1111-201604174336
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boiron, L.
- Joura, E.
- Largeron, N.
- Prager, B.
- Uhart, M.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
HPV vaccination in India
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study
Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
HPV vaccination in India
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study
Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study
HPV vaccination in India
Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study
Decline in HPV-vaccination uptake in Denmark – the association between HPV-related media coverage and HPV-vaccination
Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model